A new cytotoxic trichothecene macrolide from the endophyte Myrothecium roridum

Planta Med. 2010 Jul;76(10):1004-6. doi: 10.1055/s-0029-1240897. Epub 2010 Mar 1.

Abstract

A new cytotoxic roridin-type trichothecene macrolide named roritoxin E(1) was characterized from the solid culture of Myrothecium roridum IFB-E091 (residing originally inside Artemisia annua root), together with the known compounds lumichrome (2), (22 E,24 S)-cerevisterol (3), and (22 E,24 R)-6 beta-methoxy-ergosta-7,22-diene-3 beta,5 alpha-diol (4). The structure of the new macrolide (1) was elucidated by a combination of spectroscopic (UV, IR, MS, and 1D and 2D NMR) analyses. Compound 1 was demonstrated to be inhibitory in vitro against the gastric carcinoma SGC-7901 and hepatocarcinoma SMMC-7721 cell lines, with IC (50) values of 0.26 and 10.54 microg/mL, respectively. 5-Fluorouracil co-assayed as a positive control had an IC (50) value of 6.66 microg/mL against SGC-7901 cells, and it demonstrated only a 9.98 % growth inhibition against SMMC-7721 cells at 10 microg/mL.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / isolation & purification
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Artemisia annua
  • Biological Products / chemistry
  • Biological Products / pharmacology
  • Biological Products / therapeutic use*
  • Carcinoma / drug therapy*
  • Cell Line, Tumor
  • Humans
  • Hypocreales / chemistry*
  • Inhibitory Concentration 50
  • Liver Neoplasms / drug therapy*
  • Macrolides / isolation & purification
  • Macrolides / pharmacology
  • Macrolides / therapeutic use*
  • Molecular Structure
  • Plant Roots
  • Stomach Neoplasms / drug therapy*
  • Trichothecenes / isolation & purification
  • Trichothecenes / pharmacology
  • Trichothecenes / therapeutic use*

Substances

  • Antineoplastic Agents
  • Biological Products
  • Macrolides
  • Trichothecenes
  • roritoxin E